Bronwen Bastone - 28 Apr 2022 Form 3 Insider Report for Enfusion, Inc. (ENFN)

Role
Chief People Officer
Signature
/s/ Blake Nielsen, as Attorney-in-Fact
Issuer symbol
ENFN
Transactions as of
28 Apr 2022
Transactions value $
$0
Form type
3
Filing time
09 May 2022, 19:07:44 UTC
Next filing
17 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ENFN Class A Common Stock 70,588 28 Apr 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan. The restricted stock units vest as follows: 26,473, 17,646, 17,646 and 8,823 on each of September 9, 2022, 2023, 2024 and 2025, respectively, with 8,825, 8,823, 8,823 and 8,823 of each respective vesting tranche subject to the achievement of performance milestones.

Remarks:

Exhibit 24 - Power of Attorney